United States sets the pace for implantable brain-computer interfaces
Briefly

The United States has developed a strong regulatory framework for implantable brain-computer interfaces, attracting both researchers and investment, although it raises international equity concerns.
Bashford states that the FDA has a well-established process for reviewing implantable BCI technology, which has contributed to the U.S. leading in this emerging field.
Read at Nature
[
|
]